JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142849

beta-Carotene, Antioxidant

Be the first to review this product! Submit a review

|

(0 Publication)

MW 536.9 Da, Purity >97%. Carotenoid precursor of vitamin A. High-affinity antagonist for RARα, RARβ, and RARγ. Modulates intracellular redox status affecting redox-sensitive pathways involved in the regulation of cell cycle progression and apoptosis. Active in vivo and in vitro.
1 Images
Chemical Structure - beta-Carotene, Antioxidant (AB142849)
  • Chemical Structure

Lab

Chemical Structure - beta-Carotene, Antioxidant (AB142849)

2D chemical structure image of ab142849, beta-Carotene, Antioxidant

Key facts

CAS number

7235-40-7

Purity

>97%

Form

Solid

form

Molecular weight

536.9 Da

Molecular formula

C<sub>4</sub><sub>0</sub>H<sub>5</sub><sub>6</sub>

PubChem

5280489

Nature

Synthetic

Solubility

For more Solubility (Complete) data for BETA-CAROTENE (7 total), please visit the HSDB record page.

Biochemical name

beta-Carotene

Biological description

Carotenoid precursor of vitamin A. High-affinity antagonist for RARα, RARβ, and RARγ. Modulates intracellular redox status affecting redox-sensitive pathways involved in the regulation of cell cycle progression and apoptosis. Active in vivo and in vitro.

Canonical smiles

CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C

Isomeric smiles

CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C

InChi

InChI=1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+

InChiKey

OENHQHLEOONYIE-JLTXGRSLSA-N

IUPAC Name

1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene

style
left-column

Complementary Products

Biochemicals

AB120747

Trolox, Antioxidant vitamin E derivative

Cellular Activation - Trolox, Antioxidant vitamin E derivative (AB120747)

  • 0
  • 0
Primary Antibodies

AB252244

Anti-ZBTB20 antibody [4A3] - BSA and Azide free

Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZBTB20 antibody [4A3] - BSA and Azide free (AB252244)

  • 0
  • 0
Biochemicals

AB146419

4-P-PDOT, MT2 selective melatonin receptor antagonist

Chemical Structure - 4-P-PDOT, MT2 selective melatonin receptor antagonist (AB146419)

  • 0
  • 0
Primary Antibodies

AB18207

Anti-beta III Tubulin antibody - Neuronal Marker

BOND RX™ Validated|Lab Essentials|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-beta III Tubulin antibody - Neuronal Marker (AB18207)

  • 5
  • 67
style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

OATP1B1 also known as SLCO1B1 is a solute carrier organic anion transporter protein with a mass of approximately 85 kDa. This protein operates mechanically by transporting endogenous compounds and xenobiotics such as drugs across liver cell membranes. The primary expression of OATP1B1 occurs in the liver specifically on the basolateral membrane of hepatocytes. This localization facilitates its essential role in hepatic uptake of a variety of substances playing a critical role in pharmacokinetics.
Biological function summary

OATP1B1 contributes prominently to drug metabolism and clearance. It actively transports diverse substrates including bile acids bilirubin and drugs such as statins. While not part of a larger complex OATP1B1 functions alongside other hepatic transporters to ensure efficient clearance and detoxification processes in the liver. The activity of OATP1B1 is fundamental for maintaining drug concentrations within therapeutic ranges thereby protecting against toxicity.

Pathways

OATP1B1 is part of the hepatic drug metabolic pathway and the bile acid synthesis pathway. It works in coordination with other transporters like OATP1B3 and NTCP which also mediate hepatic uptake of organic anions and bile acids. The interaction among these transporters regulates the systemic levels of endogenous compounds and the clearance of therapeutic drugs influencing their efficacy and safety profiles.

OATP1B1 is linked to altered drug metabolism leading to statin-associated myopathy. Genetic variations in the OATP1B1 gene can reduce transporter function resulting in increased plasma concentration of statins which correlates with myopathy risk. Additionally OATP1B1 mutations may affect bilirubin handling contributing to conditions such as Rotor syndrome. Through these associations OATP1B1 interacts with other proteins affecting drug safety and disease states emphasizing its relevance in personalized medicine.
style
left-column
style
left-column

Product protocols

style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com